Hims & Hers Health Inc (NYSE: HIMS) started this week on a positive note after announcing its expansion into menopause-related treatments – a large and underserved market.However, the rally is fading rather quickly. On Friday, the telehealth stock tanked another 15% as Andrew Dudum, the company’s chief executive, confirmed he’s…
Paramount Skydance employees are set to face a substantial wave of layoffs under the leadership of David Ellison, Variety…
Kering SA, the French luxury conglomerate and parent company of Gucci, is in advanced discussions to sell its beauty…
This week brought a mix of political stalemate, global diplomacy, and market unease as Washington remained mired in a…
A €17 billion ($19.72 billion) joint bid by Bouygues Telecom, Iliad-owned Free and Orange for most of the assets…
Hungary has suddenly found itself at the center of an massive diplomatic project: hosting a high-stakes meeting between US…
Zions Bancorporation (NASDAQ: ZION) nosedived this week after reporting a $50 million write-off tied to fraudulent loans. The sell-off…
A turbulent Friday across Europe as the BBC faces a formal rebuke from Ofcom over a “misleading” Gaza documentary,…
Hims & Hers Health Inc (NYSE: HIMS) started this week on a positive note after announcing its expansion into…